FORMULATE Trademark

Trademark Overview


On Friday, November 13, 2020, a trademark application was filed for FORMULATE with the United States Patent and Trademark Office. The USPTO has given the FORMULATE trademark a serial number of 90318479. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 2, 2024. This trademark is owned by Formulate Bioscience, Inc.. The FORMULATE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for diseases, disorders, and conditions in neurology, immunology, oncology, endocrinology, and central nervous system; human endocannabinoid system-based therapies used for controlling body's responses to factors effecting physiology and homeostasis; therapeutic agents for binding and activating encannabinoid receptors

Pharmaceutical research and development services; research and development services in the field of endocannabinoid systems; providing medical and scientific research information in the field of endocannabinoid systems and endocannabinoid system-based therapies

General Information


Serial Number90318479
Word MarkFORMULATE
Filing DateFriday, November 13, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Description of MarkThe mark consists of a six sided figure with the empty outline of a branch on the lower right side with the word FORMULATE to the right.
Goods and ServicesPharmaceutical preparations for diseases, disorders, and conditions in neurology, immunology, oncology, endocrinology, and central nervous system; human endocannabinoid system-based therapies used for controlling body's responses to factors effecting physiology and homeostasis; therapeutic agents for binding and activating encannabinoid receptors
NOT AVAILABLE"FORMULATE"
Goods and ServicesPharmaceutical research and development services; research and development services in the field of endocannabinoid systems; providing medical and scientific research information in the field of endocannabinoid systems and endocannabinoid system-based therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFormulate Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Party NameFormulate Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Wednesday, January 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 17, 2020NEW APPLICATION ENTERED
Thursday, January 14, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, April 23, 2021ASSIGNED TO EXAMINER
Sunday, April 25, 2021NON-FINAL ACTION WRITTEN
Sunday, April 25, 2021NON-FINAL ACTION E-MAILED
Sunday, April 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 16, 2022SOU TEAS EXTENSION RECEIVED
Sunday, January 16, 2022SOU EXTENSION 1 FILED
Sunday, January 16, 2022SOU EXTENSION 1 GRANTED
Tuesday, January 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 30, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 30, 2022SOU EXTENSION 2 FILED
Friday, December 30, 2022SOU EXTENSION 2 GRANTED
Tuesday, January 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 18, 2023SOU TEAS EXTENSION RECEIVED
Sunday, June 18, 2023SOU EXTENSION 3 FILED
Sunday, June 18, 2023SOU EXTENSION 3 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU EXTENSION 4 FILED
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 7, 2023SOU EXTENSION 4 GRANTED
Saturday, December 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 2, 2024SOU EXTENSION 5 FILED
Tuesday, July 2, 2024SOU EXTENSION 5 GRANTED
Tuesday, July 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED